StonvexLoading…
StonvexStonvexStonvexCore line items from DIBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $22.39M | $89.62M | $66.65M | $44.68M |
Operating Income | $-3.32M | $-18.97M | $-16.66M | $-11.97M |
Net Income | $-2.17M | $-13.67M | $-12.63M | $-9.12M |
EPS (Diluted) | $-0.06 | $-0.38 | $-0.35 | $-0.26 |
Total Assets | $121.85M | $132.11M | $135.20M | $138.57M |
Total Liabilities | $37.89M | $38.53M | $41.20M | $43.71M |
Cash & Equivalents | $20.32M | $22.88M | $19.94M | $22.43M |
Free Cash Flow OCF − CapEx | $827.00K | $-3.20M | $-6.82M | $-5.32M |
Shares Outstanding | 35.45M | 36.85M | 36.61M | 36.25M |